Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 642

1.

Consensus statement on the use of gonadotropin-releasing hormone analogs in children.

Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR; ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM.

Pediatrics. 2009 Apr;123(4):e752-62. doi: 10.1542/peds.2008-1783. Epub 2009 Mar 30. Review.

PMID:
19332438
2.

[Effect of treatment with gonadotropin releasing hormone analogues in girls with idiopathic central precocious puberty].

Ságodi L, Sólyom E, Lombay B, Almási A, Vámosi I.

Orv Hetil. 2012 Mar 18;153(11):418-24. doi: 10.1556/OH.2012.29320. Hungarian.

PMID:
22390866
3.

[Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].

Chen SK, Fan X, Tang Q.

Zhongguo Dang Dai Er Ke Za Zhi. 2009 May;11(5):374-6. Chinese.

PMID:
19470261
4.
5.
7.
8.

Final height, gonadal function and bone mineral density of adolescent males with central precocious puberty after therapy with gonadotropin-releasing hormone analogues.

Bertelloni S, Baroncelli GI, Ferdeghini M, Menchini-Fabris F, Saggese G.

Eur J Pediatr. 2000 May;159(5):369-74.

PMID:
10834524
9.

Effects of luteinizing hormone-releasing hormone agonists on final height in luteinizing hormone-releasing hormone-dependent precocious puberty.

Oerter KE, Manasco PK, Barnes KM, Jones J, Hill S, Cutler GB Jr.

Acta Paediatr Suppl. 1993 Mar;388:62-8; discussion 69. Review. No abstract available.

PMID:
8329833
10.

Gonadotropin releasing hormone agonist treatment to increase final stature in children with precocious puberty: a meta-analysis.

Li P, Li Y, Yang CL.

Medicine (Baltimore). 2014 Dec;93(27):e260. doi: 10.1097/MD.0000000000000260. Review.

12.

Adequacy of a single unstimulated luteinizing hormone level to diagnose central precocious puberty in girls.

Houk CP, Kunselman AR, Lee PA.

Pediatrics. 2009 Jun;123(6):e1059-63. doi: 10.1542/peds.2008-1180.

PMID:
19482738
13.

Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.

Bertelloni S, Mul D.

Asian J Androl. 2008 Jul;10(4):525-34. doi: 10.1111/j.1745-7262.2008.00409.x. Review.

14.

Bone mineral density and body composition in girls with idiopathic central precocious puberty before and after treatment with a gonadotropin-releasing hormone agonist.

Alessandri SB, Pereira Fde A, Villela RA, Antonini SR, Elias PC, Martinelli CE Jr, Castro Md, Moreira AC, Paula FJ.

Clinics (Sao Paulo). 2012;67(6):591-6.

16.

GNRH analog therapy in girls with early puberty is associated with the achievement of predicted final height but also with increased risk of polycystic ovary syndrome.

Chiavaroli V, Liberati M, D'Antonio F, Masuccio F, Capanna R, Verrotti A, Chiarelli F, Mohn A.

Eur J Endocrinol. 2010 Jul;163(1):55-62. doi: 10.1530/EJE-09-1102. Epub 2010 Mar 31.

17.

Treatment of central precocious puberty.

Kaplowitz PB.

Curr Opin Endocrinol Diabetes Obes. 2009 Feb;16(1):31-6. doi: 10.1097/MED.0b013e328320a650. Review.

PMID:
19104235
18.

Adult height in advanced puberty with or without gonadotropin hormone releasing hormone analog treatment.

Couto-Silva AC, Adan L, Trivin C, Brauner R.

J Pediatr Endocrinol Metab. 2002 Mar;15(3):297-305.

PMID:
11924932
19.

Precocious puberty and statural growth.

Carel JC, Lahlou N, Roger M, Chaussain JL.

Hum Reprod Update. 2004 Mar-Apr;10(2):135-47. Review.

20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk